FIGURE 3.

Effect of empagliflozin on new onset of gout or initiation of antigout medication during follow‐up (on‐treatment). ^†Per 1000 patient‐years. ^‡Based on Cox regression with terms for age, sex, geographic region, baseline body mass index, baseline glycated haemoglobin, baseline estimated glomerular filtration rate, and treatment. ^§Analysis performed in patients not on antigout medication at baseline (n = 6607). ^¶Analysis performed in all patients (n = 7020). CI, confidence interval; HR, hazard ratio